Health Care & Life Sciences

Endocyte faces big decisions with new cancer drug

September 29, 2014
J.K. Wall
Endocyte's lead drug showed big impact on lung cancer patients, but some analysts think the company should scrap it for a newer drug that is more powerful.
More

The Interview Issue: Ron Ellis

September 27, 2014
J.K. Wall
Ron Ellis has been CEO of the drug discovery firm Endocyte Inc. since 1996. When he moved to West Lafayette to take the job, he wouldn’t let his wife paint the interior of their new house—for fear he’d be looking for a new job soon. Endocyte has yet to generate any revenue.
More

IU Health CFO: 3 years to go in difficult transition

September 26, 2014
J.K. Wall
Kitchell Watch videoIn the past two years, IU Health has laid off 935 people, halted construction of a major bed tower, sold off health clinics and decided to close its proton-therapy center. But there are three more years of changes to come, said CFO Ryan Kitchell.
More

Experts: Telemedicine can bridge mental health gap

September 25, 2014
Associated Press
Modern technology offers a way to deliver much-needed mental health care to rural sections of Indiana where little or none is available, experts told a legislative study committee Thursday.
More

Advocates seek action on Indiana Medicaid plan

September 25, 2014
Associated Press
Health care advocates and industry lobbyists are asking federal officials for speedy approval of Indiana's request for a Medicaid expansion.
More

Rise in bed sores pushes state medical errors to new high

September 25, 2014
 Associated Press and IBJ Staff
Overall, 111 medical errors were reported in 2013, the biggest number in any year since the state began reporting them in 2006.
More

Major Health to put new $89 million hospital along I-74

September 24, 2014
J.K. Wall
Major Health Partners will construct the new hospital on the north edge of Shelbyville, after nearly a decade of shifting services to that location. Construction could begin next month.
More

LDI acquisition could be latest springboard for growth

September 23, 2014
Jeff Newman
Indianapolis-based private investment company LDI Ltd. has acquired a small biotech manufacturer in a deal it says could be the launching point for many more acquisitions.
More

IU Health to bypass Indy next year on Obamacare exchange

September 22, 2014
J.K. Wall
IU Health Plans, the insurance arm of the Indianapolis-based hospital system, is limiting itself to three middle-size markets next year—Bloomington, Lafayette and Muncie—even though the bulk of its facilities is in the metro area.
More

FDA approves Eli Lilly's injectable diabetes drug

September 18, 2014
Associated Press
The agency on Thursday cleared the drug, Trulicity, as a weekly injection to improve blood sugar control in patients with type 2 diabetes, which affects more than 26 million Americans.
More

Obamacare enrollment at 7.3 million people, official says

September 18, 2014
Bloomberg News
That’s a 9-percent reduction from the government’s May estimate of 8 million, which reflected only how many people had signed up, not how many had paid and were enrolled in the coverage.
More

Testosterone drugs need study on heart risks, FDA panel says

September 18, 2014
Bloomberg News
Drugmakers, including Eli Lilly and Co., should conduct new trials to assess the heart risks of testosterone therapies used by millions of men last year, advisers to U.S. regulators said.
More

Abortion-related complaints filed against doctors

September 17, 2014
Associated Press
Attorney General Greg Zoeller's office filed licensing complaints Wednesday against an Illinois doctor facing misdemeanor charges in Indiana and against three physicians who perform abortions in Indianapolis.
More

Community Health plans $175M expansion of East facilities

September 17, 2014
J.K. Wall
Community executives said the investment and projects, which will begin this fall and extend over several years, prove their long-term commitment to the east side of the city.
More

FDA set to review testosterone-boosting drug usage

September 16, 2014
Bloomberg News
Testosterone supplements used last year by about 2.3 million men are spurring debates over how necessary and safe they may be, even as U.S. regulators consider approving a new product.
More

Lilly to pay AstraZeneca up to $500M in Alzheimer’s push

September 16, 2014
Bloomberg News
The two companies will work together to develop AZD3293, which belongs to a novel class of drugs called BACE inhibitors that block production of amyloid, a protein that causes plaque to build up in the brain of Alzheimer’s patients.
More

Sheriffs: Mentally ill people swamping Indiana jails

September 15, 2014
Associated Press
County jails have become the "insane asylum" for Indiana as state hospital care for the mentally ill has declined, a sheriff told a legislative committee in Indianapolis on Monday.
More

Recent wins worth $4B to Lilly market value

September 15, 2014
J.K. Wall
Lilly is finally putting meat on the bones of its predictions about its experimental diabetes and cancer drugs. That gives investors the certainty they crave that Lilly’s future revenue won’t remain in its 2014 doldrums.
More

Lilly cancer drug fares well in late-stage study

September 12, 2014
Associated Press
Eli Lilly and Co. said Friday its potential colorectal cancer drug Cyramza helped patients on chemotherapy with advanced cases of the disease survive longer than patients on chemotherapy alone.
More

Lilly receives European marketing OK for new insulin

September 10, 2014
Associated Press
European regulators have approved a long-lasting insulin from Eli Lilly and Co. and German drugmaker Boehringer Ingelheim that is the subject of patent-infringement litigation with French rival Sanofi.
More

Feds OKs $1.8 million for health exchange helpers

September 9, 2014
Associated Press
The U.S. Department of Health and Human Services is sending Indiana money to help the state's health care plan navigators sign up more residents through a federally run exchange.
More

Startup Companion Diagnostics trying to work through bankruptcy

September 8, 2014
J.K. Wall
Companion Diagnostics Inc., a biotech company that relocated to Indiana from Connecticut in 2010, has entered bankruptcy reorganization while it tries to develop a therapy for inflammation.
More

Insurer competition stiffens, but tax credits may shrink, on Obamacare exchangesRestricted Content

September 6, 2014
J.K. Wall
When Hoosiers start shopping on the Obamacare exchanges again in November, they’ll find new, lower-priced competitors and modest price increases that are much lower than insurers initially proposed. But that doesn’t mean they’ll save money.
More

Obamacare tax rule that split appeals courts gets rehearing

September 3, 2011
Bloomberg News
The full U.S. Court of Appeals will rehear a case on Obamacare tax subsidies, granting a government request in a move that may reduce chances of a new Supreme Court showdown over a central part of the law.
More

Lilly says new insulin fares better than rival's in late-stage tests

September 4, 2014
Associated Press
The Indianapolis-based drugmaker said Thursday that peglispro produced statistically significant lower blood sugar levels in patients when compared to people who took the Sanofi insulin Lantus in two late-stage studies of people with type 1 diabetes.
More
Page  1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
ADVERTISEMENT